Experimental model for acute kidney injury caused by uropathogenic Escherichia coli
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue
Abstract
Introduction: Acute kidney injury (AKI) is the rapid deterioration of renal function, diagnosed on the basis of an increase in serum creatinine and abnormal urinary parameters. AKI is associated with increased risk of mortality or chronic kidney disease (CKD).The aim of the study was to develop an experimental model for AKI resulting from Escherichia coli-induced pyelonephritis. E. coli was isolated from a patient with clinical symptoms of urinary tract infection (UTI).Material/Methods: The study included three groups of female Wistar rats (groups 1, 2 and 3), in which pyelonephritis was induced by transurethral inoculation with highly virulent E. coli (105, 107 and 109 cfu/ml, respectively). Urine and blood samples for analysis were obtained prior to the inoculation (day 0), as well as 7, 14 and 21 days thereafter.Results: Aside from a microbiological examination of urine samples, daily urine output, serum creatinine (CreaS), creatinine clearance (CrCl), interleukin 6 (IL-6), fractional excretion of sodium (FENa) and fractional excretion of urea (FEUrea) were determined. A histopathological examination of kidney and urinary bladder specimens was conducted as well. While UTI-related pyelonephritis developed irrespective of E. coli inoculum size, AKI was observed only following transurethral administration of E. coli at the intermediate and high dose, i.e. 107 and 109 cfu/ml, respectively (group 2 and 3). Discussion: An increase in CreaS and abnormal diuresis were accompanied by changes in parameters specific for various forms of AKI, i.e. FENa and FEUrea. Based on these changes, administration of E. coli at 107 cfu/ml was demonstrated to induce renal AKI, whereas inoculation with 109 cfu/ml seemed to cause not only ascending pyelonephritis, but perhaps also bacteremia and urosepsis (prerenal component of AKI).
Authors and Affiliations
Beata Skowron, Agnieszka Baranowska, Jolanta Kaszuba-Zwoińska, Grażyna Więcek, Anna Malska-Woźniak, Piotr Heczko, Magdalena Strus
Keywords
Related Articles
- EP ID EP218429
- DOI 10.5604/01.3001.0010.3833
- Views 134
- Downloads 0
Effectiveness and safety of probiotic preparations in clinical treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is characterized by an aggressive immune response to luminal antigens including those of commensal microbiota, which are essential for intestinal homeostasis and appear to play a role in...
Wybrane aspekty zakażeń Chlamydophila pneumoniae
Chlamydophila pneumoniae (Chl. pneumoniae) została taksonomicznie wyodrębniona ze szczepu TWAR - skrót od dwóch szczepów wyizolowanych od ludzi: TW-183 (materiał z oka dziecka na Tajwanie w 1965 r.) i AR-39 (materiał z w...
Ocena potencjalnej wartości prognostycznej produktu genu Bmi-1 oraz wybranych czynników związanych z proliferacją (Ki-67) i apoptozą (p53) w guzach typu neuroblastycznego
Wpływ hemodializy na białka cytoszkieletu błon erytrocytarnych
Wzrokowe potencjały wywołane w diagnostyce neuropatii nerwu wzrokowego towarzyszącej chorobom nerek
Przewlekłej niewydolności nerek towarzyszy wiele powikłań neurologicznych. Wskutek akumulacji toksyn mocznicowych dochodzi do uszkodzenia aksonów z ich wtórną demielinizacją, co powoduje rozwój polineuropatii u 60‑100% c...